CAROL TAVANI: Open Payments
NPI 1053386441 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 5 payments from 3 companies in 2025. Trend: 2023 $76 · 2024 $79 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $146 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: AUSTEDO XR, REXULTI, INGREZZA.
Industry payments across DE — which companies pay providers there.
